Compound 1744
Identifiers
- Canonical SMILES:
O[C@](C1CCCC1)(C1CCN(CCCOc2ccc(cc2)C#N)CC1)c1ccccc1
- IUPAC name:
4-(3-{4-[(R)-cyclopentyl(hydroxy)benzyl]piperidin-1-yl}propoxy)benzonitrile
- InChi:
InChI=1S/C27H34N2O2/c28-21-22-11-13-26(14-12-22)31-20-6-17-29-18-15-25(16-19-29)27(30,24-9-4-5-10-24)23-7-2-1-3-8-23/h1-3,7-8,11-14,24-25,30H,4-6,9-10,15-20H2/t27-/m1/s1
- InChiKey:
QBITUTDDFZQXDO-HHHXNRCGSA-N
External links
![]() 49791890 |
![]() CHEMBL3126187 |
2S6 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 3 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MENIN / MLL | 6.57 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 418.26 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 4.91 | |||
TPSA | 56.49 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 3 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
24472025 | MIV-3R | MEN1 O00255 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 6.57 | |
24472025 | MIV-3R | MEN1 O00255 |
|
Biochemical assay | Isothermal Titration Calorimetry | pKd (dissociation constant, -log10) | 6.55 | |
24472025 | MIV-3R | MEN1 O00255 |
|
Cellular assay | cellular viability MLL-AF9 | MLL-AF9 | pEC50 (half maximal effective concentration, -log10) | 5.39 |
24472025 | MIV-3R | MEN1 O00255 |
|
Cellular assay | cellular viability MV4-11 | MV4-11 | pEC50 (half maximal effective concentration, -log10) | 5.43 |
24472025 | MIV-3R | MEN1 O00255 |
|
Cellular assay | cellular viability MOLM-13 | MOLM-13 | pEC50 (half maximal effective concentration, -log10) | 5.13 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6628 | Cycrimine | DB00942 | |
0.6489 | Tramadol | DB00193 | |
0.6437 | Trihexyphenidyl | DB00376 | |
0.6304 | Venlafaxine | DB00285 | |
0.6250 | Procyclidine | DB00387 | |
0.6207 | Tridihexethyl | DB00505 | |
0.6147 | KH064 | DB04287 | |
0.5934 | Quifenadine | DB13713 | |
0.5851 | Nisoxetine | DB09186 | |
0.5818 | Ansofaxine | DB15052 | |
0.5773 | (R)-Fluoxetine | DB08472 | |
0.5773 | (S)-Fluoxetine | DB08544 | |
0.5773 | Fluoxetine | DB00472 | |
0.5747 | Diphenidol | DB01231 | |
0.5714 | Aliskiren | DB09026 |